A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE4
Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
- Status
- COMPLETED
- Phase
- PHASE2
Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of REGN668 Administered Subcutaneously to Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Simplified Insulin Protocol Using Lantus in Elderly
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE2
SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE3
Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel
- Status
- TERMINATED
- Phase
- PHASE2
Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
- Status
- COMPLETED
- Phase
- PHASE2